The added value of diffusion weighted MRI over standard dynamic liver MRI in characterization of focal liver lesions

Main Article Content

Hayder Suhail Najm Alareer
Hayder Jasim Taher
Hussein Abed Dakhil
Ayoob Dinar Abdullah
Ahmed Mohamedbaqer Easa
Raad Ajeel Bustan

Keywords

Magnetic Resonance Imaging, diffusion-weighted MRI, focal liver lesions

Abstract

Background: The study aims to assay the value of diffusion-weighted MR imaging over conventional dynamic liver MRI in the characterization and distinguishing of localized benign and malignant alterations in liver mass.
Methods: All liver MRI scans taken at Imam Khomeini Hospital Imaging Center from November 2018 to October 2021 were studied. Demographic information of patients was recorded. One hundred and forty patients with 221 liver lesions and focal liver tumors were evaluated using TSE T2WI, GE T1WI, 3-T MRI tests. Dynamic imaging was performed using T1 THRIVE. The results were compared with histopathology, laboratory and other previous radiological results (US &/or MSCT) performed on all patients. All collected
data were analysis with SPSS VER 18 software.


Results: Among the 140 individuals studied, 221 liver lesions were identified. The average age of the patients was 51.1±12.4 years, of all the patients investigated in the present study, there were 68 men and 72 women. The lesions were cysts (24), hemangiomas (81), FNH (9), adenomas, (10), peliosis hepatis (4), HCC (33), metastasis (58), cholangiocarcinoma (1), and Epithelioid hemangioendothelioma (1). means of ADC at the Cutoff point ≤1000 corresponded to sensitivity, specificity, positive and negative predictive value, and accuracy (100 %, 96 %, 95 %, 100, and 98 %). the diagnostic indicators of dynamic research obtained as follows specificity, sensitivity, negative and positive predictive value, and accuracy found accordingly (%, 97 %, 96 p%, 98 %, and 98 %).
Conclusion: We expect to minimize the number of biopsies and costs by using DWI over dynamic MRI to identify the features of liver lesions (malignant or benign). Using DWI on dynamic MRI results to identify liver malignant or benign lesions is expected to minimize the number and the costs of biopsies.

Abstract 272 | pdf Downloads 115

References

1. Parikh T, Drew SJ, Lee VS, Wong S, Hecht EM, Babb JS, et al. Focal liver lesion detection and characterization with diffusion-weighted MR
imaging: comparison with standard breath-hold T2-weighted imaging. Radiology. 2008 , 246(3), 812-22.
2. Hussain SM, Zondervan PE, IJzermans JN, Schalm SW, de Man RA, et al . Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. Radiographics. 2002, 22(5), 1023-36.
3. Taouli B, & Koh DM. Diffusion-weighted MR imaging of the liver. Radiology. 2010, 254(1), 47.
4. Alonso-Torres A, Fernández-Cuadrado J, Pinilla I, Parrón M, de Vicente E, et al. Multidetector CT in the evaluation of potential living donors for liver transplantation. Radiographics. 2005, 25(4), 1017-30.
5. Robinson P J, & Ward J. MRI of the Liver: A Practical Guide. CRC Press,2016.
6. Vergara ML, Fernández M, & Pereira R. Diffusion-weighted MRI characterization of solid liver lesions. Revista Chilena De Radiología.
2010, 16(1), 510.
7. Kim T, Murakami T, Takahashi S, Hori M, Tsuda K, & Nakamura H. Diffusion-weighted singleshot echoplanar MR imaging for liver disease.
AJR. American journal of roentgenology. 1999, 173(2), 393-8.
8. Feuerlein S, Pauls S, Juchems MS, Stuber T, Hoffmann MH, Brambs HJ, et al. Pitfalls in abdominal diffusion-weighted imaging: how
predictive is restricted water diffusion for malignancy. American Journal of Roentgenology. 2009, 193(4), 1070-16.
9. Ichikawa T, Haradome H, Hachiya J, Nitatori T, & Araki T. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR. American journal of roentgenology. 1998, 170(2), 397-402.
10. Silva AC, Evans JM, McCullough AE, Jatoi MA, Vargas HE, & Hara AK. MR imaging of hypervascular liver masses: a review of current techniques. Radiographics. 2009, 29(2), 385-402.
11. Bozgeyik Z, Onur MR, & Poyraz AK. The role of diffusion weighted magnetic resonance imaging in oncologic settings. Quantitative imaging in medicine and surgery. 2013, 3(5), 269.
12. Goshima S, Kanematsu M, Kondo H, Yokoyama R, Kajita K, Tsuge Y, et al. Diffusion‐weighted imaging of the liver: optimizing b value for the
detection and characterization of benign and malignant hepatic lesions. Journal of Magnetic Resonance Imaging: An Official Journal of the
International Society for Magnetic Resonance in Medicine. 2008, 28(3), 691-7.
13. Ba-Ssalamah A, Qayyum A, Bastati N, Fakhrai N, Herold CJ, & Caseiro Alves F. P4 radiology of hepatobiliary diseases with gadoxetic acidenhanced MRI as a biomarker. Expert review of gastroenterology & hepatology. 2014, 8(2), 147-60.
14. Kilickesmez O, Bayramoglu S, Inci E, & Cimilli T. Value of apparent diffusion coefficient measurement for discrimination of focal benign
and malignant hepatic masses. Journal of medical imaging and radiation oncology. 2009, 53(1), 50-5.
15. Crocetti D, Palmieri A, Pedullà G, Pasta V, D’Orazi V, & Grazi GL. Peliosis hepatis: Personal experience and literature review. World
Journal of Gastroenterology. 2015, 21(46), 13188.
16. Nasu K, Kuroki Y, Tsukamoto T, Nakajima H, Mori K, & Minami M. Diffusion-weighted imaging of surgically resected hepatocellular
carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade. American Journal of Roentgenology. 2009, 193(2), 438-44.
17. Chung YE, Kim MJ, Park YN, Choi JY, Pyo JY, Kim YC, et al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics.2009, 29(3), 683-700.
18. Mehrabi A, Kashfi A, Fonouni H, Schemmer P, Schmied BM, Hallscheidt P, etal. Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2006, 107(9), 2108-21.
19. Soyer P, Corno L, Boudiaf M, Aout M, Sirol M, Placé V, et al. Differentiation between cavernous hemangiomas and untreated malignant neoplasms of the liver with free-breathing diffusionweighted MR imaging: comparison with T2-weighted fast spin-echo MR imaging. European journal of radiology. 2011, 80(2), 316-24.
20. ZADEH, Firoozeh Abolhasani, et al. Cytotoxicity evaluation of environmentally friendly synthesis Copper/Zinc bimetallic nanoparticles on MCF-7 cancer cells. Rendiconti Lincei. Scienze Fisiche e Naturali, 2022, 1-7.
21. ROHMAH, Martina Kurnia, et al. Modulatory role of dietary curcumin and resveratrol on growth performance, serum immunity responses,
mucus enzymes activity, antioxidant capacity and serum and mucus biochemicals in the common carp, Cyprinus carpio exposed to abamectin. Fish & Shellfish Immunology, 2022, 129: 221-230.
22. ARIF, Anam, et al. The functions and molecular mechanisms of Tribbles homolog 3 (TRIB3) implicated in the pathophysiology of cancer.
International Immunopharmacology, 2023, 114: 109581.
23. MARGIANA, Ria, et al. Functions and therapeutic interventions of non-coding RNAs associated with TLR signaling pathway in
atherosclerosis. Cellular Signalling, 2022, 100: 110471.
24. H. A. Al-Hchaimi, M. F. Alhamaidah, H. Alkhfaji, M. T. Qasim, A. H. Al-Nussairi and H. S. Abd-Alzahra, "Intraoperative Fluid Management for Major Neurosurgery: Narrative study," 2022 International Symposium on Multidisciplinary Studies and Innovative Technologies (ISMSIT), 2022, pp. 311-314, doi: 10.1109/ISMSIT56059.2022.9932659.
25. MOHAMMED, Zainab; QASIM, Maytham T.The Relationship between Insulin Resistance and Hypertension in Patient with Hypertensive. HIV
Nursing, 2022, 22.2: 1659–1663-1659–1663.
26. LEI, Zimeng, et al. Detection of abemaciclib, an anti-breast cancer agent, using a new electrochemical DNA biosensor. Frontiers in Chemistry, 2022, 10.
27. BASHAR, Bashar S., et al. Application of novel Fe3O4/Zn-metal organic framework magnetic nanostructures as an antimicrobial agent and
magnetic nanocatalyst in the synthesis of heterocyclic compounds. Frontiers in Chemistry, 2022, 10.

Most read articles by the same author(s)